Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications

Abstract Background Polyglycerol is an attractive hydrophilic building block of amphiphilic copolymers for biomedical and pharmaceutical applications due to its biocompatibility, facile chemical modification, and anti-fouling activity. Herein we introduce theranostic nanoemulsions incorporating anti...

Full description

Bibliographic Details
Main Authors: Trang Huyen Le Kim, Hwiseok Jun, Jin Ho Kim, Keunchil Park, Jee Seon Kim, Yoon Sung Nam
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2017-10-01
Series:Biomaterials Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40824-017-0108-4
_version_ 1827333215269945344
author Trang Huyen Le Kim
Hwiseok Jun
Jin Ho Kim
Keunchil Park
Jee Seon Kim
Yoon Sung Nam
author_facet Trang Huyen Le Kim
Hwiseok Jun
Jin Ho Kim
Keunchil Park
Jee Seon Kim
Yoon Sung Nam
author_sort Trang Huyen Le Kim
collection DOAJ
description Abstract Background Polyglycerol is an attractive hydrophilic building block of amphiphilic copolymers for biomedical and pharmaceutical applications due to its biocompatibility, facile chemical modification, and anti-fouling activity. Herein we introduce theranostic nanoemulsions incorporating anti-cancer therapeutic and contrast agents using linear polyglycerol-poly(ε-caprolactone) diblock copolymers (PG-b-PCL). Lipiodol is used as a core oil that dissolves paclitaxel and serves as a contrast agent for computer tomography (CT). Methods PG-b-PCL is synthesized by three-step processes: polymerization of ethoxyethyl glycerol ether; ring-opening polymerization of ε-caprolactone; and deprotection of the PEEGE block. In vitro cytotoxicity of the polyglycerolated lipiodol nanoemulsions is demonstrated using HeLa ovarian cancer cells. The applicability of the prepared nanoemulsions as a contrast agent for CT imaging is also evaluated using micro-CT. Results Three compositions of PG-b-PCL with different block lengths are synthesized to prepare nanoemulsions. The polyglycerolated lipiodol nanoemulsions exhibit excellent anti-cancer activities, while placebo nanoemulsions have no significant cytotoxicity under the same condition. Micro-CT imaging of the nanoemulsions confirms the ability of nanoemulsions as a contrast agent. Conclusions This study suggests that PG-b-PCL is a promising polymeric emulsifier for effective stabilization and surface functionalization of drug delivery nanocarriers for therapeutic and imaging agents.
first_indexed 2024-03-07T17:18:00Z
format Article
id doaj.art-49d397dba9b04460a9a384067811d90e
institution Directory Open Access Journal
issn 2055-7124
language English
last_indexed 2024-03-07T17:18:00Z
publishDate 2017-10-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Biomaterials Research
spelling doaj.art-49d397dba9b04460a9a384067811d90e2024-03-02T21:45:15ZengAmerican Association for the Advancement of Science (AAAS)Biomaterials Research2055-71242017-10-0121111010.1186/s40824-017-0108-4Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applicationsTrang Huyen Le Kim0Hwiseok Jun1Jin Ho Kim2Keunchil Park3Jee Seon Kim4Yoon Sung Nam5Department of Materials Science and Engineering, Korea Advanced Institute of Science and TechnologyDepartment of Materials Science and Engineering, Korea Advanced Institute of Science and TechnologySamsung Medical Center, Samsung Biomedical Research InstituteSamsung Biomedical Research Institute and Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of MedicineDepartment of Materials Science and Engineering, Korea Advanced Institute of Science and TechnologyDepartment of Materials Science and Engineering and KAIST Institute for the NanoCentury, Korea Advanced Institute of Science and TechnologyAbstract Background Polyglycerol is an attractive hydrophilic building block of amphiphilic copolymers for biomedical and pharmaceutical applications due to its biocompatibility, facile chemical modification, and anti-fouling activity. Herein we introduce theranostic nanoemulsions incorporating anti-cancer therapeutic and contrast agents using linear polyglycerol-poly(ε-caprolactone) diblock copolymers (PG-b-PCL). Lipiodol is used as a core oil that dissolves paclitaxel and serves as a contrast agent for computer tomography (CT). Methods PG-b-PCL is synthesized by three-step processes: polymerization of ethoxyethyl glycerol ether; ring-opening polymerization of ε-caprolactone; and deprotection of the PEEGE block. In vitro cytotoxicity of the polyglycerolated lipiodol nanoemulsions is demonstrated using HeLa ovarian cancer cells. The applicability of the prepared nanoemulsions as a contrast agent for CT imaging is also evaluated using micro-CT. Results Three compositions of PG-b-PCL with different block lengths are synthesized to prepare nanoemulsions. The polyglycerolated lipiodol nanoemulsions exhibit excellent anti-cancer activities, while placebo nanoemulsions have no significant cytotoxicity under the same condition. Micro-CT imaging of the nanoemulsions confirms the ability of nanoemulsions as a contrast agent. Conclusions This study suggests that PG-b-PCL is a promising polymeric emulsifier for effective stabilization and surface functionalization of drug delivery nanocarriers for therapeutic and imaging agents.http://link.springer.com/article/10.1186/s40824-017-0108-4PolyglycerolAmphiphilic copolymersNanoemulsionsLipiodolPaclitaxelCancer
spellingShingle Trang Huyen Le Kim
Hwiseok Jun
Jin Ho Kim
Keunchil Park
Jee Seon Kim
Yoon Sung Nam
Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
Biomaterials Research
Polyglycerol
Amphiphilic copolymers
Nanoemulsions
Lipiodol
Paclitaxel
Cancer
title Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
title_full Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
title_fullStr Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
title_full_unstemmed Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
title_short Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications
title_sort lipiodol nanoemulsions stabilized with polyglycerol polycaprolactone block copolymers for theranostic applications
topic Polyglycerol
Amphiphilic copolymers
Nanoemulsions
Lipiodol
Paclitaxel
Cancer
url http://link.springer.com/article/10.1186/s40824-017-0108-4
work_keys_str_mv AT tranghuyenlekim lipiodolnanoemulsionsstabilizedwithpolyglycerolpolycaprolactoneblockcopolymersfortheranosticapplications
AT hwiseokjun lipiodolnanoemulsionsstabilizedwithpolyglycerolpolycaprolactoneblockcopolymersfortheranosticapplications
AT jinhokim lipiodolnanoemulsionsstabilizedwithpolyglycerolpolycaprolactoneblockcopolymersfortheranosticapplications
AT keunchilpark lipiodolnanoemulsionsstabilizedwithpolyglycerolpolycaprolactoneblockcopolymersfortheranosticapplications
AT jeeseonkim lipiodolnanoemulsionsstabilizedwithpolyglycerolpolycaprolactoneblockcopolymersfortheranosticapplications
AT yoonsungnam lipiodolnanoemulsionsstabilizedwithpolyglycerolpolycaprolactoneblockcopolymersfortheranosticapplications